Drug Patent Expirations for Mar 9, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

EVISTA (raloxifene hydrochloride)
Lilly
Patent number: 6,458,811
Expiration Date: Mar 10, 2017

EVISTA (raloxifene hydrochloride)
Lilly
Patent number: 6,894,064
Expiration Date: Mar 10, 2017

EVISTA (raloxifene hydrochloride)
Lilly
Patent number: 6,797,719
Expiration Date: Mar 10, 2017

EVISTA (raloxifene hydrochloride)
Lilly
Patent number: 8,030,330
Expiration Date: Mar 10, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


This post was originally published on this site
Comments are closed.